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Abstract
Background: There is increasing evidence that programmed cell death can be triggered during
cardiopulmonary bypass (CPB) and may be involved in postoperative complications. The
purpose of this study was to investigate whether apoptosis occurs during aortic valve surgery
and whether modifying temperature during CPB has any influence on cardiomyocyte apoptotic
death rate.
Methods: 20 patients undergoing elective aortic valve replacement for aortic stenosis were
randomly assigned to either moderate hypothermic (ModHT group, n = 10, 28°C) or mild
hypothermic (MiHT group, n = 10, 34°C) CPB. Myocardial samples were obtained from the right
atrium before and after weaning from CPB. Specimens were examined for apoptosis by flow
cytometry analysis of annexin V-propidium iodide (PI) and Fas death receptor staining.
Results: In the ModHT group, non apoptotic non necrotic cells (annexin negative, PI negative)
decreased after CPB, while early apoptotic (annexin positive, PI negative) and late apoptotic or
necrotic (PI positive) cells increased. In contrast, no change in the different cell populations was
observed over time in the MiHT group. Fas expression rose after reperfusion in the ModHT
group but not in MiHT patients, in which there was even a trend for a lower Fas staining after
CPB (p = 0.08). In ModHT patients, a prolonged ischemic time tended to induce a higher increase
of Fas (p = 0.061).
Conclusion: Our data suggest that apoptosis signal cascade is activated at early stages during
aortic valve replacement under ModHT CPB. This apoptosis induction can effectively be
attenuated by a more normothermic procedure.
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1. Background
Cardiomyocyte apoptosis has been involved in the patho-
physiology of various cardiovascular diseases such as
ischemic cardiomyopathy, hibernating myocardium,
heart failure, reperfusion injury, and transplant rejection
[1,2]. Recent reports have documented the prevalence of
programmed cardiomyocyte death in open heart surgery
under cardiopulmonary bypass (CPB), where it may con-
tribute in parallel with necrosis to increase the bulk of
myocardial death cells [3-12]. Apoptosis that occurs in
this clinical setting can be induced by a wide variety of
conditions and agents, including reactive oxygen-derived
species, calcium and pressure overload, mechanical stress,
nitric oxide, tumor necrosis factor, and angiotensin II
[2,13]. It remains unclear whether apoptosis is a primary
or a secondary event within cardiac surgery, and while
some authors have related it to postoperative myocardial
stunning [9] and non cardiac complications [3,4]; others
have observed that inhibition of apoptosis has no impact
on postischemic left ventricle functional recovery [14].
One of the reasons for scarce data concerning apoptosis
and its pathophysiological consequences during cardiac
surgery is the inferiority of the various techniques used to
detect apoptotic cell changes. The most commonly used
method, histochemical staining of the fragmented DNA
by the TUNEL assay (in situ terminal deoxynucleotidyl-
transferase mediated dUTP nick end-labeling), has a poor
positive predicted value, as it labels not only fragmented
DNA but also DNA in the process of repair as well as
necrotic tissue [2,15]. Besides, the duration of the apop-
totic program (12 to 24 hours) far exceeds the intraopera-
tive window for sample acquisition (2 to 3 hours) [9],
which render the observation of late signs of apoptotic
cascade like DNA fragmentation useless. The investigation
of early apoptotic signs, such as the translocation of mem-
brane phospholipids or the activation of intracellular pro-
teins, using more accurate tools may overcome these
limitations.
Rationale for the use of hypothermia during cardiac sur-
gery is based on its capacity to reversibly reduce metabolic
activity in all cells and subcellular organelles, further lim-
iting the rate of consumption of intracellular high-energy
phosphates stores and ischemic injury [16]. Despite of
this positive effect, hypothermia has also a deleterious
influence on platelet function and increases citrate toxic-
ity, with subsequent reduction in serum ionized calcium,
leading to reversible coagulopathy, dysrhythmias, and
depression of myocardial contractility [17,18]. The role of
temperature for apoptosis is controversial and may be
dual depending on the degree of hypothermia. While
deep hypothermic circulatory arrest may activate apop-
totic pathways [5], less aggressive hypothermia seems to
inhibit them [19]. The temperature limits at which apop-
tosis is enhanced or attenuated should be accurately
defined.
The purpose of this study was to investigate whether
apoptosis occurs during elective aortic valve replacement
for aortic stenosis and whether CPB temperature has any
influence on cardiomyocyte apoptotic death rate. The rea-
son for selecting non urgent isolated aortic valve patients
was their greater homogeneity with respect to other car-
diac pathologies, and the possibility of avoiding underly-
ing causes of myocardial apoptosis other than cardiac
surgery, such as ischemic cardiomyopathy or congestive
heart failure. To adequate operative sample acquisition
timing to the development of the apoptotic program we
analyzed early stages apoptosis by flow cytometric analy-
sis of annexin V and death receptor Fas staining.
2. Material and methods
2.1. Patients
After approval by our institution ethics committee on
human research, informed consent was obtained from 20
patients who were scheduled for elective aortic valve
replacement for aortic stenosis. Anesthesia was induced
with fentanyl and etomidate, and was maintained with
sevoflurane and fentanyl. Surgery was performed through
a median sternotomy with standard CPB. Myocardial pro-
tection was obtained with intermittent retrograde admin-
istration of cold (4°C) blood cardioplegia (4:1 blood-to-
crystalloid mixture). Patients were randomly assigned to
one of two groups: moderate hypothermic CPB (ModHT
group, n = 10) or mild hypothermic CPB (MiHT group, n
= 10). After institution of CPB, patients in the ModHT
group were cooled until core (nasopharyngeal) tempera-
ture reached 28°C, whereas the temperature of patients in
the MiHT group was just let to drop until it leveled off
spontaneously. Baseline biometric characteristics and
CPB data of trial groups are shown in Table 1.
2.2. Sample acquisition
Using a sharp scalpel, myocardial biopsy specimens
(approximately 300 mm3) were obtained from the right
atrial appendage of each patient before the start of CPB
and after weaning from extracorporeal circulation. To
minimize technical influences on apoptotic and necrotic
measurements, particular care was taken not to mechani-
cally irritate the site of atrial tissue harvesting with the for-
ceps and with the venous cannula. Blood samples were
also taken from the coronary sinus at the same time of
heart biopsy collection for analysis of necrosis.
2.3. Isolation of cardiomyocytes
A single cell suspension was obtained from the heart tis-
sue samples immediately after removal by mechanical dis-
aggregation with a 50 µm filtered Medimachine system
(BD Bioscience, CA, USA). Cells were washed with coldJournal of Cardiothoracic Surgery 2007, 2:7 http://www.cardiothoracicsurgery.org/content/2/1/7
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phosphate buffer saline (PBS) to exclude cell debris and
resuspended in culture medium (RPMI 1640; Bio-Whit-
taker, Verviers, Belgium). This procedure rendered a pre-
served viability cell population as judged by trypan blue
dye exclusion. To be sure that cardiac cells were specifi-
cally quantified, intracellular expression of the specific
protein -connexin 43- was analyzed. After fixation and
permeabilization with IntraStain kit (Dako Cytomation,
Glostrup, Denmark), cells were incubated with connexin
43 rabbit polyclonal antibody (Zymed Laboratories, San
Francisco, CA, USA). Binding was revealed by phycoeryth-
rin conjugated goat anti-rabbit IgG (Jackson Immunore-
search, Baltimore, USA) and flow cytometry. The
antibodies were initially titrated for optimal concentra-
tion, and cells incubation with only phycoerythrin-anti-
body was used as negative control.
2.4. Analysis of apoptosis
Apoptosis was measured by staining cells with a combina-
tion of fluoresceinated (FITC) annexin V and propidium
iodide (PI) and by Fas death receptor quantification on
cell membrane.
Changes in the plasma membrane are one of the earliest
morphological features of apoptosis. In apoptotic cells,
the membrane phospholipid phosphatidylserine is trans-
located from the inner to the outer leaflet of the plasma
membrane, thereby exposing phosphatidylserine to the
external cellular environment. Annexin V is a 35–36 kD
Ca2+-dependent phospholipid-binding protein that has a
high affinity for phosphatidylserine. Because externaliza-
tion of phosphatidylserine occurs in the early stages of
apoptosis, annexin V staining can identify apoptotic cells
earlier than assays based on nuclear changes like DNA
fragmentation, and precedes the loss of membrane integ-
rity which accompanies the latest stages of cell death
resulting from either apoptotic or necrotic processes.
Therefore, staining with annexin V in conjunction with
vital dye such as PI allows to identify early apoptotic cells
(annexin positive, PI negative) and non apoptotic non
necrotic cells (annexin negative, PI negative) (Figure 1).
The assay does not identify between cells that have already
completed the apoptotic program and those that have
died as a result of a necrotic pathway, because in either
case the dead cells will stain the same (annexin positive,
PI positive). Briefly, the cells to analyze with the annexin
V-PI method were resuspended in 100 µl of binding buffer
(140 mM NaCl, 2.5 mM CaCl2, 10 mM HEPES; pH 7.4).
Next, 5 µl of annexin V-FITC (Pharmingen, CA, USA) were
added and incubated for 15 minutes at room temperature
preserved of the light. Then, 100 µl of PI-PBS solution (50
mg/ml) (PI; Sigma, St Louis, MO, USA) were added and
immediately data acquisition was made in the flow
cytometer in order to avoid cell damage and the diffusion
of PI through cell membrane.
Fas molecule (APO-1/CD95) belongs to the tumor necro-
sis factor receptor superfamily and may induce apoptosis
by Fas-Fas ligand (Fas-L) binding. The Fas/Fas-L system is
an essential part of the death receptor pathway regulating
the induction of a rapid apoptosis independent of mito-
chondria. We measured Fas by membrane cell staining
with FITC conjugated anti-CD95 monoclonal antibody
(BD Biosciences) (Figure 1). Mouse IgG1 irrelevant anti-
body FITC conjugated was used as negative control of
staining. After 15 minutes incubation at room tempera-
ture and dark, these cells were washed to remove the
excess of antibody and fixed with 2% formaldehyde. Anti-
bodies were used following manufacturer recommenda-
tions. In all cases, we have used a FACSort (BD Bioscience)
Table 1: Demographic, clinical, and CPB data of trial groups
ModHT Group (n = 10) MiHT Group (n = 10) p Value
Age (y) 70.6 ± 9.7 67.7 ± 12.3 0.565
Female, n (%) 4 (40%) 4 (40%) 1.000
Hypertension, n (%) 6 (60%) 6 (60%) 1.000
Smoking history, n (%) 4 (40% 2 (20%) 0.626
Diabetes, n (%) 2 (20%) 1 (10%) 1.000
Hyperlipidemia, n (%) 4 (40%) 2 (20%) 0.626
Atrial fibrillation, n (%) 2 (20%) 4 (40%) 0.626
LVEF (%) 62.2 ± 17.1 57.8 ± 17.8 0.580
CPB time (min) 85.2 ± 11.3 87.5 ± 21.1 0.765
Aortic crossclamping time (min) 59.2 ± 7.8 59.0 ± 16.6 0.973
Minimal core CPB temperature (nasopharyngeal) (°C) 28.2 ± 1.1 34.5 ± 0.9 < 0.001
Need for postCPB inotropic support, n (%) 2 (20%) 2 (20%) 1.000
Results are expressed as means ± standard deviations, unless otherwise indicated.
CPB, cardiopulmonary bypass; LVEF, left ventricular ejection fraction.Journal of Cardiothoracic Surgery 2007, 2:7 http://www.cardiothoracicsurgery.org/content/2/1/7
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flow cytometer to measure the cell-associated fluores-
cence with CellQuest and Paint-a-gate Pro analysis soft-
ware (BD Bioscience).
2.5. Analysis of necrosis
Cardiomyocyte loss by necrosis was assessed by determi-
nation of creatine kinase, creatine kinase myocardial
band, lactate dehydrogenase, troponin I, and lactate.
2.6. Statistical analysis
Data are presented as mean ± standard deviation. The
χ2test and the two-tailed unpaired Student's t test were
used when appropriate to compare the results between
groups. Values from the different biochemical variables
before and after CPB were compared using the two-tailed
paired Student's t test. Correlation between the number of
early apoptotic cells, Fas levels, and operative times was
studied using Pearson's correlation coefficient. Differ-
ences were considered significant when p value was less
than 0.05. Statistical analyses were performed with the
software package SPSS for Windows, release 10.0.7 (SPSS
Inc, Chicago, Ill, USA).
3. Results
Groups were well matched in terms of age, sex, prevalence
of cardiovascular risk factors and atrial fibrillation, preop-
erative left ventricular function, and duration of CPB and
aortic crossclamping (Table 1).
Changes in cardiomyocyte death status during the opera-
tive procedure are summarized in Table 2. Apoptotic and
necrotic parameters did not differ between groups before
the start of CPB. In the ModHT group, non apoptotic non
necrotic cells (annexin negative, PI negative) decreased
immediately after CPB, while early apoptotic (annexin
positive, PI negative) and late apoptotic or necrotic (PI
Flow cytometry analysis from a 75-year-old patient that underwent aortic valve replacement under ModHT CPB for aortic ste- nosis Figure 1
Flow cytometry analysis from a 75-year-old patient that underwent aortic valve replacement under ModHT CPB for aortic ste-
nosis. From left to right (basal and reperfusion): dot-plot bidimensional diagram of annexin V-propidium iodide staining, and 
histogram showing Fas positive cardiomyocytes. Data are expressed as percentage of cells.
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positive) cells increased. In contrast, no change among the
different cell populations for apoptosis or necrosis was
observed over time in the MiHT group. ModHT patients
exhibited a higher percentage of early apoptotic cells and
a lower number of live cardiomyocytes than MiHT
patients after CPB. Fas expression rose after reperfusion in
the ModHT group but not in the MiHT, in which there was
even a trend for a lower Fas staining at the end of CPB (p
= 0.08). A significant correlation was observed between
the Fas level and the percentage of annexin positive-PI
negative cells after CPB (r = 0.814, p < 0.001) (Figure 2).
In the ModHT group, a prolonged aortic crossclamping
time tended to induce a higher increase of Fas over time (r
= 0.685, p = 0.061) (Figure 3). Molecular markers of myo-
cardial necrosis increased after CPB in a similar way in
both groups, with the exception of lactate dehydrogenase
that did not change consistently after reperfusion, and cre-
atine kinase myocardial band that rose only in the MiHT
group.
4. Discussion
Apoptosis has been reported not only to occur during
open heart surgery but also to be related to postoperative
myocardial stunning, renal insufficiency, and cerebral
dysfunction [3,4,9]. Cardiac surgery combines two pro-
apoptotic stimuli: ischemia-reperfusion injury and CPB.
Both processes lead to the activation of vascular endothe-
lial cells and neutrophils, thereby stimulating cellular cal-
cium overload, and the generation of reactive oxygen-
derived species and cytokines that may further initiate the
apoptotic program in cardiomyocytes [2,13]. Serum of
patients after CPB has been shown to have a strong proa-
poptotic activity on human endothelial cells [7]. Several
recent studies have demonstrated that both the mitochon-
drial and the death receptor pathways of caspase activa-
tion are triggered during open heart surgery leading to
myocardial apoptosis. Schmitt and coworkers found a
postreperfusion highly significant 3.4 ± 0.4-fold increase
of the mitochondrial respiratory chain protein -cyto-
chrome c- in the cytosol of atrial myocytes during coro-
nary artery bypass grafting [9]. Activation of caspases-3
and -7 and an elevated release of soluble Fas and Fas lig-
and have also been detected at the end of extracorporeal
circulation [6,8,10].
Strategies towards a less apoptogenic procedure appear to
be a goal to achieve excellence in cardiac surgery and may
include shortening of ischemic and CPB times, increased
use of intraaortic balloon pump and noncatecholamine
inotropes, addition of antiapoptotic medication, or mod-
ulation of intraoperative temperature.
Hypothermia improves resistance to ischemia-reper-
fusion injury in the myocardium. Protection afforded by
low temperature may be linked to a wide variety of effects,
including reduction of ATP store depletion, inhibition of
endothelial cell expression of E-selectin, modification of
cell death signaling pathways, and preservation of gene
expression for mitochondrial proteins [16]. Nevertheless,
the impact of intraoperative hypothermia on cardiomyo-
cyte apoptosis during cardiac surgical procedures remains
controversial. Cooper and colleagues have observed an
increased rate of apoptosis in duodenal and myocardial
tissue from pigs subjected to deep hypothermic circula-
tory arrest as compared to normothermic CPB controls
[5]. Other authors, on the contrary, have assessed by gene
array analysis a protective effect of hypothermia (30°C)
on the cardioplegia-arrested rabbit heart, based on its
ability for decreasing the expression of proapoptotic pro-
teins (p53, bak) and promoting antiapoptotic factors (Bcl-
x) [19]. This finding is also supported by studies including
experimental models of cerebral hypoxia in which hypo-
Table 2: Cell death status over time
Basal (ModHT group/MiHT group) Reperfusion 
(ModHT group/MiHT group)
p Value 
(ModHT group/MiHT group)
Non apoptotic non necrotic cells 
(annexin negative, PI negative) (%)
73.86 ± 18.49/67.28 ± 16.40 51.20 ± 23.88/71.71 ± 11.35 a 0.002/0.307
Early apoptotic cells (annexin positive, PI 
negative) (%)
16.45 ± 13.36/20.70 ± 12.21 33.21 ± 17.85/17.62 ± 8.06 a 0.003/0.180
Late apoptotic or necrotic cells (annexin 
positive, PI positive) (%)
6.97 ± 3.68/10.49 ± 5.92 11.45 ± 5.11/8.90 ± 5.36 0.009/0.513
Fas positive cells (%) 15.14 ± 17.85/20.03 ± 14.99 31.34 ± 22.54/14.30 ± 10.66 0.009/0.081
CK (IU/L) 53.1 ± 21.6/60.2 ± 23.7 167.1 ± 158.5/153.8 ± 87.9 0.045/0.011
CK-MB (IU/L) 29.13 ± 18.20/20.00 ± 3.62 42.25 ± 33.80/37.70 ± 12.18 0.355/0.001
LDH (IU/L) 363.0 ± 94.2/334.5 ± 61.6 385.4 ± 152.7/363.5 ± 80.1 0.723/0.240
Troponin I (µg/L) 0.32 ± 0.33/0.22 ± 0.15 1.48 ± 1.37/1.45 ± 0.53 0.029/< 0.001
Lactate (mmol/L) 1.53 ± 0.88/1.62 ± 0.91 3.60 ± 1.32/3.19 ± 1.19 0.002/0.005
Results are expressed as means ± standard deviations.
a p < 0.05 compared to ModHT group.
CK, creatine kinase; CK-MB, creatine kinase myocardial band; LDH, lactate dehydrogenase; PI, propidium iodide.Journal of Cardiothoracic Surgery 2007, 2:7 http://www.cardiothoracicsurgery.org/content/2/1/7
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thermia mitigated post-ischemic programmed cell death
[20-22].
Our results suggest an additive pro-apoptotic effect of
moderate hypothermia that may superimpose on the per
se apoptogenic state of CPB, and that might be involved in
the decreased systolic performance often observed with
cooling [17,18]. Two early reversible morphological fea-
tures of apoptosis signal cascade activation, phosphatidyl-
serine externalization and Fas expression in the plasma
membrane, increased after reperfusion in the ModHT
group but not in MiHT patients.
The annexin V staining as a method for cell death analysis
has been mainly applied in lymphoid disorders, but there
is increasing evidence that it is also useful for the detection
of apoptotic cardiomyocytes [1,23,24]. When compared
to the TUNEL assay, both methods have shown a similar
sensitivity and specificity [15]. Scholz and Leaes have
recently employed annexin V technique for the analysis of
neutrophil and lymphoid apoptosis that occurred during
CPB in pigs and humans, respectively [11,12]. Annexin V
staining reveal phosphatidylserine outer leaflet mem-
brane exposure, which is one of the earliest hallmarks of
cells undergoing apoptosis [1,15,23,24]. Annexin positive
cardiomyocytes retain contractile function but exhibit a
decreased cell width indicative of cell shrinkage, and a
markedly elevated mitochondrial free Ca2+ [24]. In our
study, annexin V positive-PI negative cells were detected
in both groups before the start of CPB, but whereas in the
ModHT group the number of cardiomyocytes that had
initiated the apoptotic program increased after reper-
fusion, in MiHT patients it remained unchanged.
The biological relevance of Fas has been mainly proved in
relation to T lymphocytes activity in the context of
autoimmune and hematopoietic diseases [6,8]. Neverthe-
less, Fas is also expressed in other non lymphoid cells such
as cardiomyocytes or hepatocytes [25]. In fact, it has been
shown to be involved in the pathophysiology of conges-
tive heart failure, graft rejection, end-stage cardiomyopa-
thy, and myocarditis [6]. Kawahito and Joashi have
observed elevated serum levels of the soluble form of Fas
and Fas ligand after completion of cardiac surgical proce-
dures under moderate hypothermic CPB [6,8]. They also
found prolonged operative times to induce higher serum
concentrations of Fas. In the present study, a significant
but similar percentage of cardiomyocytes were Fas posi-
tive before CPB in both groups. A higher Fas expression
was observed after reperfusion in ModHT patients, but
not in those operated under mild hypothermia, which
tended to show less Fas positive cells after weaning from
CPB. In addition, in the ModHT group there was a trend
for a higher increase in Fas staining with longer ischemic
times. Phanithi and colleagues have also demonstrated
that mild hypothermia (33°C) reduced Fas expression in
a rat model of reversible cerebral ischemia when com-
pared to normothermic controls [22]. We measured the
membrane-bound form of Fas, which is known to be of
far greater importance in the apoptotic process than the
soluble form of the molecule that was determined in pre-
vious studies [6,8].
In conclusion, our data show that apoptosis signal cas-
cade is activated at early stages in human myocardium
Correlation observed in both study groups between the rise  of Fas over time (before CPB to reperfusion) and the dura- tion of aortic crossclamping using Pearson's correlation coef- ficient Figure 3
Correlation observed in both study groups between the rise 
of Fas over time (before CPB to reperfusion) and the dura-
tion of aortic crossclamping using Pearson's correlation coef-
ficient.
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during aortic valve replacement under ModHT CPB. This
apoptosis induction can effectively be attenuated by a
near-normothermic strategy. In our experience, the bio-
chemical benefit of mild hypothermia is not apparently
based on the reduction of bypass times or the use of less
postoperative inotropic support, and should response to a
direct impact of temperature on cell membrane stability
and death receptor signaling pathway.
4.1. Limitations of the study
Heart tissue samples were harvested from the right atrial
appendage with the intention of obtaining an appropriate
amount of tissue without impairing cardiac function. This
strategy has been previously reported for the study of
apoptosis during CPB [9]. Nevertheless, the distribution
of the cardioplegia infused through the coronary sinus is
not uniform in the entire heart, and left cavities may be
better preserved than the right ones. The hypothesis that
our findings in the right atrium mirror changes in the left
ventricular muscle must be made with cautious and repre-
sents a limitation of the present work.
The percentage of cardiomyocytes that have initiated the
apoptotic program at the time of first sample acquisition
(preCPB) seems remarkably high in both groups (more
than 16% in annexin assay, and more than 15% in Fas
staining), which may indicate a lack of specificity of both
techniques. Although tissue damage during biopsy collec-
tion might have contributed to artifact the results, we
hypothesize that our data may reliably reflect the state of
apoptosis in atrial myocardium just before CPB. In fact,
contributing factors such us anesthesia induction, sternot-
omy, or cannulation may trigger the apoptotic cascade
before the start of CPB, as it has been suggested by previ-
ous works [10]. Besides, apoptosis is a reversible process
until the downstream caspases (caspase-3, -6, -7) are acti-
vated [2], so not all the annexin positive-PI negative and
Fas positive cells will necessarily complete the apoptotic
program and die.
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